Climb Bio Inc.
CLYM | NASDAQ
$10.24
-$0.09 (-0.87%)
At close: Oct 30, 2026, 3:59 PM ET
$10.25
+$0.01 (+0.10%)
Pre-market:
Nov 2, 2026, 4:36 AM ET
Market Data
Market Cap $588.15M
Enterprise Value $406.34M
Beta 0.08
Average Volume 1.41M
Shares Outstanding (Diluted) 76.15M
Shares Change YoY 12.68%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US28658R1068
Price Performance
Price Change 1M -10.7%
Price Change 3M -13.9%
Price Change 6M 14.9%
Price Change YTD 156.0%
Price Change 1Y 399.5%
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) -27.1%
1Y CAGR (ann.) 392.8%
5Y CAGR (ann.) N/A
All-Time CAGR 13.4%
Valuation
PE Ratio -12.34
Forward PE N/A
PEG Ratio 0.61
Forward PEG 4.10
PS Ratio N/A
Forward PS 770.20
PB Ratio 2.46
P/FCF Ratio -11.08
P/Adj. FCF Ratio -9.61
P/OCF Ratio -14.84
EV/Sales N/A
EV/EBIT -6.83
EV/EBITDA -6.85
EV/FCF -7.66
Earnings Yield -8.1%
FCF Yield -9.0%
Adj. FCF Yield -10.4%
Financial Health
Net Cash $183.12M
Total Debt $1.31M
Cash & Short-Term Investments $183.12M
Total Assets $246.29M
Current Ratio 31.45
Quick Ratio 31.45
Debt / Equity Ratio 0.01
Debt / EBITDA -0.02
Debt / FCF -0.02
OCF / Debt -40.11
Interest Coverage 0.00
Altman Z-Score 50.64
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -15.3%
Returns
Return on Assets -23.4%
Return on Equity -31.8%
Return on Invested Capital -26.9%
Return on Capital Employed -26.9%
Return on Tangible Assets -23.4%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y 53.8%
EPS CAGR 5Y 24.2%
EPS CAGR 10Y N/A
FCF CAGR 3Y -85.9%
FCF CAGR 5Y -5.4%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 7
EPS Growth Next 3Y -37.4%
Revenue Growth Next 3Y N/A
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$0.20
EPS Growth Est (next Q) 5.3%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $28.00
Price Target Upside 173.4%
Cash Flow
Operating Cash Flow $-52.7M
Free Cash Flow $-53.07M
Adj. Free Cash Flow $-61.17M
FCF Per Share -$0.70
OCF Per Share -$0.69
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-68K
Operating Income $-64.76M
EBITDA $-59.36M
Net Income $-57.62M
EPS (Diluted) -$0.83
Revenue / Employee N/A
Profit / Employee $-2.06M
Employees 28
Add to Watchlist
Select watchlists to add or remove CLYM